Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Valion Bio (TIVC) Asset Writedowns and Impairment (2021 - 2024)

Valion Bio has reported Asset Writedowns and Impairment over the past 3 years, most recently at $338000.0 for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $338000.0; the TTM value through Dec 2024 reached $338000.0, changed N/A, while the annual FY2024 figure was $354000.0, 1006.25% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was $338000.0 at Valion Bio, up from -$5000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $338000.0 in Q4 2024 and troughed at -$28000.0 in Q2 2021.
  • A 3-year average of $55000.0 and a median of $1500.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • On a YoY basis, Asset Writedowns and Impairment climbed as much as 82.14% in 2022 and fell as far as 77.27% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at -$2000.0 in 2021, then tumbled by 150.0% to -$5000.0 in 2022, then surged by 6860.0% to $338000.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for TIVC at $338000.0 in Q4 2024, -$5000.0 in Q2 2022, and $5000.0 in Q1 2022.